Shop
-1.png)
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
November 29 2025
JAMA Dermatology has recently published the results of a retrospective cohort study evaluating the efficacy of supplementation with nicotinamide, vita...
“Clinical guidelines have progressively lowered the recommended LDL-C target for high-risk CVD patients to below 70 mg/dL, but scientific support for this target is arguably questionable.”
A review published recently in the Journal of Clinical Medicine adds to research questioning the relationship between LDL-cholesterol (LDL-C) and cardiovascular disease (CVD). Previous blogs and Research Forums have highlighted numerous studies identifying people with very high LDL-C, yet coronary artery calcium scores of zero, indicating low risk for cardiovascular events. Starting from the premise that LDL-C is a poor predictor of CVD risk, the authors of the new review argue that the preponderance of evidence does not support targeting LDL-C to below 70 mg/dL either for cardiovascular health or overall health.
The authors cite numerous studies that fail to show a linear relationship between LDL-C and CVD risk, “challenging the promotion of aggressive LDL-C reduction”—particularly for primary prevention. They also emphasize that studies have shown an association between high LDL-C and better health and increased longevity among the elderly, likely owing to superior immune function, resistance to infection, and a reduction in cancer-related mortality that has been found in individuals with the highest LDL-C.
A 2022 meta-analysis found that the benefits of statin drug therapy for reducing the incidence of stroke or heart attack, and reducing all-cause mortality, are highly inflated owing to the use of relative risk reduction rather than absolute risk reduction. This new review suggests that the small benefit statins impart may not be a consequence of lowering LDL-C, but rather, from their antithrombotic effects and other pleiotropic effects.
Submit this form and you'll receive our latest news and updates.
Two controlled trials evaluating supplemental myo-inositol have recently been published. The first, in the journal Diabe...
Learn moreA recent study has concluded that the LDL cholesterol of a specific group of people given a carbohydrate-restricted diet...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
Proposition 65 Warning
© 2025 Biotics Research Corporation - All Rights Reserved
Submit your comment